// App-Quantinova.ai

OC01.05 : STRIDER UK: a randomised controlled trial of sildenafil therapy in dismal prognosis early‐onset intrauterine growth restriction

Researchers

Presenter

  • A. Sharp

Principal Investigators

  • C. Comforth

  • R. Jackson

  • M. Turner

  • L. Kenny

  • P. Baker

  • E. Johnstone

  • A. Khalil

  • A.T. Papageorghiou

  • Z. Alfirevic

Medical Centers

  • Institute of Child Health Department of Womens and Childrens Health,University of Liverpool, Liverpool, United Kingdom

  • Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, United Kingdom

  • Irish Centre for Fetal and Neanatal Translational Research, Department of Obstetrics and Gynecology, University Collage Cork, Cork University Maternity Hospital, Cork, Republic of Ireland

  • College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, United Kingdom

  • Maternal and Fetal Health Research Centre, Central Manchester University Hospitals, NHS Foundation Trust, Manchester, United Kingdom

  • Neonatal Unit, St Georges Hospital NHS Trust, London, United Kingdom

Locations

  • United Kingdom

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Sildenafil citrate

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved